Monday, September 15, 2025

Latest

Asia-Focused Biotech SPAC Valuence Merger I Prices US$200 Million IPO

Special purpose acquisition company Valuence Merger Corp. I (Nasdaq: VMCAU) started trading on the Nasdaq Global Market today. The firm aims to raise US$200.0 million in its initial public offering.

The offering consisted of 20.0 million company units at US$10.00 per unit. Each unit contains one Class A common share and one-half of a redeemable warrant. Each whole warrant is exercisable for one common share at US$11.50 per share. The company units are currently trading under the symbol “VMCAU” while the shares and purchase warrants, once trading separately, will be trading under “VMCA” and “VMCAW”, respectively.

SVB Leerink acts as the sole bookrunner for the said offering. The underwriters were granted a 45-day overallotment option to purchase additional 3.0 million units at the same IPO price.

The blank check firm is being led by CEO Sung Yoon Woo, the CEO of South Korean private equity firm Credian Partners. The firm also expects to partner with venture capital firm CrystalBioSciences and Japan-based consulting firm Quantum Leaps,

For its target businesses, the firm said it intends to search for businesses “in Asia (excluding China, Hong Kong, and Macau) with a particular focus… in life sciences and/or sustainable technology.”


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

New Found Gold: The Strategic Maritime Resources Purchase

Amex Exploration: Revised Perron PEA Has INSANE Economics

Aris Mining: The Multi Billion Dollar Soto Norte PFS

Recommended

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Goliath Resources Hits 18.58 g/t Gold Over 5.00 Metres At Surebet

Related News

Viral Diseases Tester Virax Biolabs Prices Upsized US$6.75 Million IPO

Biopharmaceutical company Virax Biolabs Group Limited recently increased its initial public offering size as it...

Wednesday, June 22, 2022, 02:14:00 PM

RAW Rolling Papers Founder Josh Kesselman Eyes Unique IPO With QR Code Shares

Josh Kesselman, the founder and CEO of RAW Rolling Papers, has unveiled an unconventional vision...

Tuesday, June 11, 2024, 01:20:00 PM

Investment Firm-Backed SPAC Sound Point Acquisition I Prices Upsized US$225 Million IPO

Special purpose acquisition company Sound Point Acquisition Corp I (Nasdaq: SPCMU) started trading publicly on...

Wednesday, March 2, 2022, 02:23:00 PM

LegalZoom Eyes Raising US$535.4 Million On Its Nasdaq IPO

Online legal platform LegalZoom.com Inc. announced Tuesday the pricing of its scheduled initial public offering...

Wednesday, June 30, 2021, 10:14:00 AM

Tech SPAC 10X Capital Venture Acquisition III Prices Upsized US$261 Million IPO

Blank check company 10X Capital Venture Acquisition Corp. III (NYSE: VCXB.U) is looking to raise...

Wednesday, January 12, 2022, 02:18:00 PM